Skip to main content
SA

Santero Therapeutics

Charleroi, Belgium
Last funding
$8.6M
Series AJun 2023

Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance.

Backed byNewton BiocapitalSFPIMSambrinvestS.R.I.W.Pierre Drion

About Santero Therapeutics

How much funding has Santero Therapeutics raised?

Santero Therapeutics has raised $8.6M in total funding. The most recent round was Series A. The last funding was announced in June 2023.

Who are Santero Therapeutics's investors?

Santero Therapeutics's investors include Newton Biocapital, SFPIM, Sambrinvest, S.R.I.W., Pierre Drion.

Where is Santero Therapeutics headquartered?

Santero Therapeutics is headquartered in Charleroi, Belgium.

What does Santero Therapeutics do?

Santero Therapeutics seeks to provide novel medications with fresh modes of action that combat diseases with high resistance.

What stage is Santero Therapeutics at?

Santero Therapeutics is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .

MLA
"Santero Therapeutics — Funding & Investors." VCBacked, June 7, 2023, https://www.vcbacked.co/company/santero-therapeutics. Accessed November 15, 2026.
APA
VCBacked. (2023). Santero Therapeutics — Funding & Investors. Retrieved November 15, 2026, from https://www.vcbacked.co/company/santero-therapeutics
Wikipedia (cite web)
{{cite web |title=Santero Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/santero-therapeutics |website=VCBacked |access-date=November 15, 2026}}

Profile data sourced and verified per the VCbacked methodology · Last funding round dated

Work at Santero Therapeutics? Request a listing update

Founder contacts
m***@santero.be
linkedin.com/in/●●●●●●
Emails, phones & LinkedIn · 41,000+ verified contacts
Get instant access →